• 1. Currently, the two main cytokines used during non-targeted immunotherapy treatment are:
• Your Colleagues Responded
• IL-2 and IL-18

  0%
• IFN-alpha and IL-20

  0%
• IFN-alpha and 1L-2

  0%
• TNF-alpha and TNF-alpha

  0%

• 2. Pembrolizumab is an immunotherapy agent that can be classified under both categories: checkpoint inhibitors and monoclonal antibodies.
• Your Colleagues Responded
• true

  0%
• false

  0%

• 3. What category of targeted immunotherapy does CAR T-cell therapy belong?
• Your Colleagues Responded
• Therapeutic Vaccine

  0%
• Adoptive cell therapy

  0%
• Monoclonal antibody

  0%
• Oncolytic virus therapy

  0%

• 4. Current combination immunotherapies often target which main two checkpoint inhibitors:
• Your Colleagues Responded
• CLTA-4 and PD-1

  0%
• B7 and PD-1

  0%
• LAG3 and CTLA-4

  0%
• CTLA-3 and PD-1

  0%

• 5. Which of the two main categories of immunotherapies work by activating the entire immune system to more effectively fight against cancer?
• Your Colleagues Responded
• Non-targeted immunotherapy

  0%
• Targeted immunotherapies

  0%